🔎 Trials Near Me

Acasă › Neuroblastom › Alabama

Studii clinice pentru Neuroblastom în Alabama

8 studii pentru Neuroblastom caută participanți în Alabama.

Orașe în Alabama

Text oficial al studiului (în engleză)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Hospital of Alabama, Birmingham
  • USA Health Strada Patient Care Center, Mobile
În curs de recrutareFaza 3
Până la vârsta de 30 · Toate sexele · Actualizat 2 oct. 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • University of Alabama/Children's of Alabama, Birmingham
În curs de recrutareFaza 2
Până la vârsta de 22 · Toate sexele · Actualizat 4 sept. 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • University of Alabama/Children's of Alabama, Birmingham
În curs de recrutareFaza 1/2
Până la vârsta de 26 · Toate sexele · Actualizat 3 sept. 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • University of Alabama/Children's of Alabama, Birmingham
În curs de recrutareFaza 1/2
Până la vârsta de 30 · Toate sexele · Actualizat 3 sept. 2026 · NCT06541262

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Hospital of Alabama, Birmingham
În curs de recrutareFaza 3
365 Days – 30 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital of Alabama, Birmingham
În curs de recrutareFaza 1/2
12 Months – 30 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • University of Alabama/Children's of Alabama, Birmingham
În curs de recrutareFaza 2
12 Months – 21 Years · Toate sexele · Actualizat 12 aug. 2026 · NCT05489887

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital of Alabama/UAB, Birmingham
În curs de recrutareFaza 2
18 Months – 40 Years · Toate sexele · Actualizat 12 aug. 2025 · NCT05135975

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.